CORALVILLE, Iowa, April 30, 2010 (GLOBE NEWSWIRE) -- Vivakor, Inc. (OTCBB:VIVK) announced today that its management increased the revenue outlook for its VivaThermic division. Increased global demand for disposable products used to support the stem cell research and therapy markets is following aggressive private and public funding of these markets. Vivakor's VivaThermic vials improve cryopreservation of sensitive cell types such as human stem cells.
Vivakor's Chief Executive Officer and Chief Scientific Officer, Dr. Tannin Fuja, stated, "As global demand for products supporting stem cell related markets intensifies, the potential market size for our VivaThermic vials has increased and could potentially be in excess of $20 million annually. The estimated growth of this market will accelerate with continued private and public support for life-saving stem cell therapies and the necessary research to discover them."
About Vivakor, Inc.
Vivakor™ is a biomedical/biotechnology company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds, that extend or improve life. More information can be found about Vivakor at www.vivakor.com.
FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements, including, but not limited to, statements regarding Vivakor's products and their related market potential. Forward-looking statements may be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in Vivakor's filings with the Securities and Exchange Commission, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. Vivakor undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect actual outcomes.